NOT KNOWN FACTUAL STATEMENTS ABOUT SR9009

. They found which the concentration of HBsAg secreted from the cell culture and mouse serum was lowered by CRISPR/Cas9 treatment. They concluded that a CRISPR/Cas9 program inhibited HBV replication and expression in vitro As well as in vivoThey uncovered that Cas9-mediated base enhancing is a possible strategy to overcome CHB by completely inactiv